Sector: MedicalSchering-Plough Corp (NYSE: SGP)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 165 |
Technical : | 26 |
Performance : | 200 |
Overall: | 110 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 161 |
Technical : | 64 |
Performance : | 219 |
Overall: | 154 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 162 |
Technical : | 15 |
Performance : | 233 |
Overall: | 131 |
Number of Stocks: | 305 |
Headlines
- Eisai chief Naito becomes 1st Japanese to head int'l drugmakers body
Nov 04, 2009 11:45 PM | MRK, SGP
- Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable
Nov 04, 2009 03:49 PM | MRK, SGP
- New Merck Begins Operations Worldwide
Nov 04, 2009 08:06 AM | MRK, SGP
- Début des activités de la nouvelle société Merck partout dans le monde
Nov 04, 2009 08:03 AM | MRK, SGP
- New Merck Begins Operations
Nov 04, 2009 08:01 AM | MRK, SGP
- Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors
Nov 04, 2009 07:01 AM | JNJ, PFE, SGP
- /R E P E A T -- Video B-Roll available via CNW - Merck and Schering-Plough to Complete Merger/
Nov 04, 2009 06:03 AM | MRK, SGP
- /R E P E A T -- Video B-Roll available via CNW - Merck and Schering-Plough to Complete Merger/
Nov 03, 2009 06:31 PM | MRK, SGP
- Video B-Roll available via CNW - Merck and Schering-Plough to Complete Merger
Nov 03, 2009 05:17 PM | MRK, SGP
- Component Changes Made to Dow Jones Health Care Titans 30 Index
Nov 03, 2009 04:16 PM | MRK, SGP
- Business Highlights
Nov 02, 2009 06:52 PM | BDK, CIT, HUM, MRK, PFE, SGP
- Schering-Plough Shares Hit Premerger Bump -- Fails Expectations, but Merck Deal Encouraging
Oct 23, 2009 05:51 PM | MRK, SGP
- Schering-Plough Shares Hit Premerger Bump
Oct 23, 2009 05:54 AM | MRK, SGP, TRI
- Bristol-Myers posts higher 3Q sales, lower profit
Oct 22, 2009 02:53 PM | MRK, PFE, SGP
- Earnings Preview: Bristol-Myers 3Q earnings report
Oct 21, 2009 11:53 AM | AZN, BMY, GSK, JNJ, LLY, MRK
- SGP Pays B1.75bn for Chevron Unit in China
Oct 01, 2009 04:51 PM | CVX, HK, SGP
- Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth
Sep 30, 2009 01:17 PM | ABT, CRXL, CSL, JNJ, PFE, SGP
- Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth
Sep 30, 2009 06:13 AM | ABT, CRXL, CSL, JNJ, PFE, SGP
- Abbott to buy Solvay division for $6.6B
Sep 28, 2009 04:40 PM | MRK, PFE, SGP, WYE
- Business Highlights
Sep 18, 2009 05:56 PM | MRK, MSFT, SGP
- Merck and Schering-Plough to Complete Merger Today
Nov 03, 2009 11:51 AM | MRK, SGP
- Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Oct 27, 2009 07:53 AM | LGND, MBRX, PFE, SGP
- RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on OLN, LXK, SGP, MMM, LYG and STSI
Oct 26, 2009 08:09 AM | LXK, LYG, MMM, OLN, SGP
- Fitch: Credit Quality Stable for Global Pharma Sector With Increase of New Drug Approvals in 2Q'09
Sep 11, 2009 09:52 AM | AZN, LLY, PFE, SGP, WYE
- Schering-Plough Announces Two European Filings
Aug 26, 2009 11:16 AM | SGP
- SCHERING-PLOUGH ANNOUNCES FDA APPROVAL OF SAPHRIS(R) (asenapine): for acute treatment of schizophrenia in adults and manic or mixed episodes of bipolar I disorder with or without psychotic features in adults
Aug 14, 2009 08:31 AM | SGP
- Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
Aug 14, 2009 07:00 AM | SGP
- Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX(R)
Aug 11, 2009 06:08 PM | SGP
- BenchmarkJournal.Com Free Analyst Review for PGH, JEC, PL, SGP, UPS and WCC
Aug 11, 2009 10:20 AM | JEC, PGH, PL, SGP, UPS, WCC
- Photos: New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours
Aug 11, 2009 07:47 AM | SGP
- Form 4 MCGRATH EUGENE R For: Nov 03 (10K)
Nov 04, 2009 06:48 PM
- Form 4 Colligan Thomas J For: Nov 03 (10K)
Nov 04, 2009 06:46 PM
- Form 4 PEREZ ANTONIO M For: Nov 03 (10K)
Nov 04, 2009 06:46 PM
- Form 4 WEINBACH ARTHUR F For: Nov 03 (10K)
Nov 04, 2009 06:45 PM
- Form 4 Merck & Co. Inc. For: Nov 03 Filed by: STAHL JACK L (10K)
Nov 04, 2009 06:44 PM
- Form 4 SAUNDERS BRENT L For: Nov 03 (10K)
Nov 04, 2009 06:43 PM
- Form 4 Merck & Co. Inc. For: Nov 03 Filed by: TURNER KATHRYN C (10K)
Nov 04, 2009 06:42 PM
- Form 4 SABATINO THOMAS J JR For: Nov 03 (10K)
Nov 04, 2009 06:41 PM
- Form 4 VAN OORDT ROBERT FW For: Nov 03 (10K)
Nov 04, 2009 06:40 PM
- Form 4 Queisser Lori A. For: Nov 03 (10K)
Nov 04, 2009 06:39 PM
Analyst Ratings
Share Performance
|
Period
|
SGP
|
Compare to S&P
|
| YTD |
65.59 %
|
44.35 %
|
| 4 Weeks |
0.07 %
|
-0.99 %
|
| 12 Weeks |
5.94 %
|
3.31 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -13.04 %
|
|
EPS Growth in Last Year: 2.56 %
|
|
Sales Growth in Last Quarter: -3.18 %
|
|
Sales Growth in Last Quarter: -1.68 %
|
|
